Not all scars are created equal. That's the conclusion of a new study by Weizmann Institute of Science researchers: They found that two distinct types of scars, referred to as "hot" and "cold," can ...

A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...

An FDA-approved osteoporosis treatment might nudge a mutated protein back into shape and improve heart function, according to ...

This multicenter study sheds more light on sex-based differences in aortic stenosis (AS) and argues the benefits of using cardiovascular magnetic resonance (CMR) to assess sex-based risks in AS.

Boehringer Ingelheim, IP Group, UK Respiratory Gene Therapy Consortium, and OXB launched the first-in-human clinical trial, known as LENTICLAIR 1.

Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.

A research team co-led by scientists at the University of Arizona College of Medicine—Tucson found that an osteoporosis drug ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.